Introduction
Marubi and Healtech Beijing CDMO Center Reach Equity Transaction AgreementRecently, Guangdong Marubi Biotechnology Co., Ltd. had reached an agreement with Healtech Beijing CDMO Center. Marubi will directly acquire shares in Shengzhi Runhe, thereby expanding into the new field of extracellular matrix (ECM).
Healtech Beijing CDMO Center has established a core technological platform for extracellular matrix (ECM) in the field of regenerative medical biomaterials. It provides technical upgrades and new project reserves services for manufacturing and sales-oriented enterprises, and also provides end-to-end solutions from research and development, product testing, animal testing, clinical trials, product registration, to contract manufacturing. The platform has pioneered omentum ECM technology, in which core components are extracted from porcine greater omentum matrix. This innovation overcomes challenges related to efficient omentum degreasing and decellularization while preserving active ingredients, resulting in a highly regenerative and safe biomaterial. The main clinical applications include medical aesthetics, burn/wound care, orthopedics and so on.
Healtech Tissue Engineering and Regenerative Medical Biomaterials Laboratory has undertaken the special project of "National 13th Five-Year Key R&D Plan for Biomaterials Research and Development and Organ Repair Replacement", and has achieved the transformation of scientific and technological achievements in "Engineering Preparation Technology and Product Development of Low Immunogenicity Collagen and Silk Fibroin". It holds core patents for extracellular matrix(ECM) and silk fibroin(SFM), and has also developed various research and development technologies of new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, glucan, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.
The laboratory has developed over 80 technology projects, applied for 37 national patents, obtained 12 national invention patent certificates and 6 medical device registration certificates. It provides technical upgrades and new project reserves services for manufacturers and distributors, with strategic partnerships established globally with listed companies such as Fosun Pharma, Double Crane Pharma, and So-Young Group.
Address: 2404-2405,Block B, Lize Ping An Finance Center,Fengtai District, Beijing
Phone: 0086-010-83739181
